MIMICS-2 at 1 year: 3D stent meets safety & effectiveness goals

SHARE
Feb. 11, 2018- By: Caitlin E.Cox

The TCTMD reports on Timothy Sullivan`s presentation at the International Symposium on Endovascular Therapy. In terms of 12-month primary patency, the strategy of "natural swirling flow is an alternative to antiproliferative drugs," the researcher says.

Most popular related searches

Contact supplier

Drop file here or browse